CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
chimeric antigen receptor (CAR) targeting cluster of differentiation (CD)19 and CD20 in participants with aggressive large B-cell lymphoma....
Phase 1, Phase 2
Pittsburgh, Pennsylvania, United States and 25 other locations
This study evaluates a fenretinide phospholipid suspension for the treatment of T-cell non-Hodgkin's lymphoma (NHL)....
Phase 1
Pittsburgh, Pennsylvania, United States and 9 other locations
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cells (a white blood cell responsible for fighting infections). Classic...
Phase 2
Pittsburgh, Pennsylvania, United States and 71 other locations
The primary objective of this study is to characterize the safety and tolerability of loncastuximab tesirine in combination with polatuzumab vedotin,...
Phase 1
Pittsburgh, Pennsylvania, United States and 41 other locations
The purpose of this trial is to measure the following in participants with relapsed and/or refractory B-cell lymphoma who receive epcoritama...
Phase 1, Phase 2
Pittsburgh, Pennsylvania, United States and 84 other locations
1 and Phase 2 components in subjects with advanced solid tumors and lymphoma who have progressed despite having standard therapy or for whic...
Phase 1, Phase 2
Pittsburgh, Pennsylvania, United States and 4 other locations
2 cohorts to assess safety and efficacy of emavusertib in combination with ibrutinib in participants with R/R primary central nervous system lymphoma...
Phase 1, Phase 2
Pittsburgh, Pennsylvania, United States and 42 other locations
inhibitor for the treatment of relapsed/refractory (R/R) T-cell lymphoma.. This trial will study the safety, tolerability, and anti-tumor ac...
Phase 1
Pittsburgh, Pennsylvania, United States and 21 other locations
pharmacokinetics, pharmacodynamics, and anti-tumor activity of DR-01 in adult patients with large granular lymphocytic leukemia or cytotoxic lymphomas...
Phase 1, Phase 2
Pittsburgh, Pennsylvania, United States and 35 other locations
of ALLO-501A in adults with relapsed or refractory large B-cell lymphoma and assess the safety of ALLO-501A in adults with relapsed or refra...
Phase 1, Phase 2
Pittsburgh, Pennsylvania, United States and 22 other locations
Clinical trials
Research sites
Resources
Legal